The World Health Organization (WHO) has released its HIV
drug resistance report for 2021.
WHO’s latest report gives an in-depth picture of the extent to
which drug resistance is growing, and the steps that countries
are taken to ensure people will receive effective medicine to
treat and prevent HIV.
It reveals that in 2020, 64 percent of focus countries, had
National action plans to prevent, monitor, and respond to HIV
drug resistance. These plans are informed by the Global
Action Plan on HIV drug resistance 2017–2021, a multi-
stakeholder plan coordinated and published by WHO.
WHO encourages countries to monitor resistance and
recommends that for people starting antiretroviral drugs
called pretreatment HIV drug resistance reaches a threshold
of 10 percent, then the first-line HIV treatment should be
urgently changed to a more robust dolutegravir-containing
regimen.